| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |